🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the possible benefits and side effects of adding...
Status
Terminated
Location
Ohio State University Comprehensive Cancer Center
Start Date
2021-09-27
Trial ID
NCT04956302
Treatments Being Tested
This trial will study how safely the tazemetostat works with other therapie...
Status
Withdrawn
Location
California Cancer Associates For Research And Excellence, cCARE
Start Date
2021-12-22
Trial ID
NCT05205252
The goal of this phase 2 clinical trial is to learn if patients with Multip...
Status
Recruiting
Location
Karmanos Cancer Institute
Start Date
2023-12-21
Trial ID
NCT06107738
Treatments Being Tested
The purpose of this study is to learn about how well the drug daratumumab/h...
Status
Enrolling By Invitation
Location
Mayo Clinic Rochester
Start Date
2022-03-31
Trial ID
NCT05300451
Treatments Being Tested
The goal of this clinical trial is to learn about daratumumab and hyaluroni...
Status
Withdrawn
Location
Lombardi Comprehensive Cancer Center, Georgetown University
Start Date
2025-09-26
Trial ID
NCT06046287
Treatments Being Tested
This clinical trial tests the treatment effect of home based daratumumab ad...
Status
Completed
Location
Sidney Kimmel Cancer Center at Thomas Jefferson University
Start Date
2022-11-08
Trial ID
NCT05511428
This phase II trial compares standard consolidation with daratumumab, carfi...
Status
Recruiting
Location
Roswell Park Cancer Institute
Start Date
2027-04-20
Trial ID
NCT07605416
Treatments Being Tested
This is a prospective and single arm clinical study. The goal of this clini...
Status
Unknown
Location
The First Affiliated Hospital of Wenzhou Medical University
Start Date
2024-03-01
Trial ID
NCT06455748
Treatments Being Tested
This phase II trial compares the combination of selinexor, daratumumab and ...
Status
Active Not Recruiting
Location
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Start Date
2024-07-23
Trial ID
NCT06169215
The goal of this study is to evaluate the efficacy and safety of Sonrotocla...
Status
Recruiting
Location
Peking University First Hospital
Start Date
2026-02-10
Trial ID
NCT07335887
Treatments Being Tested